2020 ePoster – Peritoneal Dialysis

N WALIA1,2, N RAO1, M GARRETT3, K YATES3, S MALONE3, C HOLMES1,4 1Bendigo Health, Bendigo, Australia, 2Austin Health, Heidelberg, Australia, 3Home Dialysis, Bendigo Health, Bendigo, Australia, 4Monash Rural Health, Bendigo, Australia Introduction: The use of proton-pump inhibitors (PPIs) has been...
D THARMARAJ1, C DENDLE2, K POLKINGHORNE1,3, M DAMASIEWICZ1,3 1Department of Nephrology, Monash Health, Clayton, Australia, 2Centre for Inflammatory Diseases, School of Clinical Sciences, Monash University and Monash Infectious Disease, Monash Health, Clayton, Australia, 3Department of Medicine, Monash University, Clayton, Australia...
D SABANAYAGAM1, M A  NICDAO1, K  CHAU1,2, K SUD1, S TARAFDAR1 1Western Sydney Local Health District, Westmead and Blacktown, Australia, 2University of Western Sydney, Blacktown, Australia Background: Most patients in Australia commencing on peritoneal dialysis (PD) are commenced on standard...
N RAO1, M  GARRETT1, K YATES1, S MALONE1, C HOLMES1 1Department of Nephrology, Bendigo Health, BENDIGO, Australia Background: Stenotrophomonas maltophilia (SM) is a low-virulence gram-negative bacillus that is an uncommon cause of peritoneal dialysis (PD) associated peritonitis. SM peritonitis is associated...
L HUANG1,2, J MAH1, J HOWARD1, L MCMAHON1,2 1Department of Renal Medicine, Box Hill Hospital, 2Department of Medicine, Eastern Health Clinical School, Monash University   Aim: To describe characteristics and clinical outcomes of incident patients treated with incremental peritoneal dialysis (InPD) compared...
C-A T BACH1, M R P DAVIES1, P F  MOUNT1,2 1Department of Nephrology, Austin Health, Heidelberg, AUSTRALIA, 2Department of Medicine, University of Melbourne, Parkville, AUSTRALIA Background: Sucroferric oxyhydroxide (SOH) is an iron-based phosphate binder. Studies have reported chronic use of SOH...
Recent Comments
    Categories